Skip to main content
. 2021 Aug 4;24(4):655–664. doi: 10.1093/neuonc/noab188

Table 2.

Characteristics of All Eligible and Efficacy Evaluable Patients (n = 70)

Characteristic Number (%)
Age (years)
 Median 7.1
 Range 3.3–19.4
Sex
 Male 32 (45.7)
 Female 38 (54.3)
Race
 White 49 (70)
 Asian 3 (4.3)
 American Indian or Alaska Native 0 (0)
 Black or African American 8 (11.4)
 Unknown 10 (14.3)
Ethnicity
 Non-Hispanic 54 (77.1)
 Hispanic 14 (20)
 Unknown 2 (2.9)
Diagnoses
 “Typical” diffuse intrinsic pontine glioma 61 (87.1)
 Glioblastoma 5 (7.1)
 Anaplastic astrocytoma 4 (5.7)